Details up front: 30 mg · retatrutide.
This should be a straightforward calculation and I keep getting two different answers.
The numbers are arbitrary; the method is what I am after.
Can someone show the working rather than just the answer?
Content assay and purity are orthogonal measurements answering orthogonal questions, and the confusion between them is one of the most expensive misreadings in this space.
The single most common reason for disagreement between a supplier content figure and an independent assay is using different standards.
| Δ mass (Da) | Most likely cause | Distinguishing feature |
|---|---|---|
| +1 | Deamidation (Asn or Gln) | New peak, slightly earlier retention |
| −17 | Loss of ammonia | Often with deamidation |
| −18 | Dehydration / succinimide | pH-dependent, reversible |
| +16 | Oxidation (Met, Trp) | Earlier retention, light-related |
| −128 | Missing Gln or Lys | Deletion sequence from synthesis |
| 0 | Isomer: racemisation or scrambling | Same mass, shifted retention |
More usefully, water content and counter-ion content are part of the gross mass but not part of the content assay result, which is why the two do not sum to label claim.
Where content data have been published from testing services on common peptides, the spread between services on identical material is typically a few per cent.
The caveat is that content assay costs more than purity, so most people do not do it, which is exactly why it is valuable on the first lot from a new supplier.
The practical summary: if you are ordering from a new supplier, budget for content assay on the first lot.
edited 3 Feb 2026 by klara_novotna — removed a claim I could not source
HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.
Submit a sampleFounded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.
Visit GL BiochemStart from what you are trying to know — whether a vial contains what the label claims — and purity does not answer that question.
Comparing content results from different laboratories requires knowing whether they both used certified reference materials or whether one used an in-house standard of unknown provenance.
It helps to be literal here: system suitability for a quantitative method is stricter than for purity because a small systematic error in the standard directly translates into an error in the sample result.
The relative standard deviation on replicate quantitations of a homogeneous sample should be below two per cent when the method is under control.
Worth noting that the standard certificate carries its own uncertainty, usually on the order of two to three per cent, which the sample result inherits.
Ask for both the purity and the content, and do not accept purity alone.
edited 4 Jan 2026 by coldpack_88 — expanded the table to cover the lower concentration
If a supplier quotes a content figure without stating the purity of their reference standard, they have not told you the uncertainty in the number.
A content assay is always paired with a purity assay because purity tells you what fraction of the measured mass is the target and content tells you the total measured mass.
If the standard and sample have different absorption coefficients at the detection wavelength, the response factors differ and the inference fails.
Quantitation against a standard requires that the standard be traceable to a national metrology institute, and certificates for research-grade standards claim that traceability.
The limitation is that a quantitative method is only as good as the standard it uses, and a cheap standard is a false economy.
If a supplier gives you content without the standard's purity, ask them to provide it.
The honest answer is that you cannot know for certain what you have without a content assay, and the purity number alone is not enough.
For peptides at 214 nanometres the response is roughly proportional to the number of peptide bonds, so truncation impurities have lower response factors and overestimate content.
One qualification: a single result from a single vial is a point estimate, and repeating the assay on a second aliquot is worth doing if the first result is surprising.
The practical summary: if you are ordering from a new supplier, budget for content assay on the first lot.
Two measures of the same vial can agree on purity and disagree on content by a few per cent, which usually means the content assay used a different standard.
If a sample shows high purity but low content, the explanation is usually that the standard used for quantitation had a different purity than claimed.
Pharmacopoeial guidance on quantitative methods specifies validation steps for linearity, range, accuracy and precision that most research-grade work does not claim to meet.
Ask for both the purity and the content, and do not accept purity alone.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.